Dalley JW, Cardinal RN, Robbins TW (2004) Prefrontal executive and
cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 28:771–784.
Dawe GS, Huff KD, Vandergriff JL, Sharp T, O'Neill MJ, Rasmussen
K (2001) Olanzapine activates the rat locus coeruleus: in vivo
electrophysiology and c-Fos immunoreactivity. Biol Psychiatry
50:510 –520.
Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ
(1994) JNK1: a protein kinase stimulated by UV light and Ha-Ras
that binds and phosphorylates the c-Jun activation domain. Cell
76:1025–1037.
Deutch AY, Duman RS (1996) The effects of antipsychotic drugs on
Fos protein expression in the prefrontal cortex: cellular localization
and pharmacological characterization. Neuroscience 70:377–389.
Dinan TG, Aston-Jones G (1984) Acute haloperidol increases impulse
activity of brain noradrenergic neurons. Brain Res 307:359 –362.
Dinan TG, Aston-Jones G (1985) Chronic haloperidol inactivates brain
noradrenergic neurons. Brain Res 325:385–388.
Dragunow M, Faull R (1989) The use of c-fos as a metabolic marker in
neuronal pathway tracing. J Neurosci Methods 29:261–265.
Dumas S, Javoy-Agid F, Hirsch E, Agid Y, Mallet J (1990) Tyrosine
hydroxylase gene expression in human ventral mesencephalon:
detection of tyrosine hydroxylase messenger RNA in neurites.
J Neurosci Res 25:569 –575.
Fadda F, Gessa GL, Marcou M, Mosca E, Rossetti Z (1984) Evidence
for dopamine autoreceptors in mesocortical dopamine neurons.
Brain Res 293:67–72.
Gius D, Cao XM, Rauscher FJ III, Cohen DR, Curran T, Sukhatme VP
(1990) Transcriptional activation and repression by Fos are independent functions: the C terminus represses immediate-early gene
expression via CArG elements. Mol Cell Biol 10:4243– 4255.
Goldman-Rakic PS (1996) Regional and cellular fractionation of working memory. Proc Natl Acad Sci U S A 93:13473–13480.
Goldman-Rakic PS (1999) The physiological approach: functional ar- chitecture of working memory and disordered cognition in schizophrenia. Biol Psychiatry 46:650 – 661.
Goldman-Rakic PS, Selemon LD (1997) Functional and anatomical
aspects of prefrontal pathology in schizophrenia. Schizophr Bull
23:437– 458.
Gronier BS, Rasmussen K (2003) Electrophysiological effects of acute
and chronic olanzapine and fluoxetine in the rat prefrontal cortex.
Neurosci Lett 349:196 –200.
Guo Z, Du X, Iacovitti L (1998) Regulation of tyrosine hydroxylase
gene expression during transdifferentiation of striatal neurons:
changes in transcription factors binding the AP-1 site. J Neurosci
18:8163– 8174.
Hebert MA, Serova LI, Sabban EL (2005) Single and repeated immobilization stress differentially trigger induction and phosphorylation
of several transcription factors and mitogen-activated protein ki- nases in the rat locus coeruleus. J Neurochem 95:484 – 498.
Herdegen T, Leah JD (1998) Inducible and constitutive transcription
factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res
Brain Res Rev 28:370 – 490.
Howard-Jones N (1985) A CIOMS ethical code for animal experimentation. WHO Chronicle 39:51–56.
Kapur S, Arenovich T, Agid O, Zipursky R, Lindborg S, Jones B (2005)
Evidence for onset of antipsychotic effects within the first 24 hours
of treatment. Am J Psychiatry 162:939 –946.
Kapur S, VanderSpek SC, Brownlee BA, Nobrega JN (2003) Antipsychotic dosing in preclinical models is often unrepresentative of the
clinical condition: a suggested solution based on in vivo occupancy. J Pharmacol Exp Ther 305:625– 631.
Kasper S, Resinger E (2003) Cognitive effects and antipsychotic treatment. Psychoneuroendocrinology 28 (Suppl 1):27–38.
Kvetnansky R, Sabban EL (1998) Stress and molecular biology of
neurotransmitter-related enzymes. Ann N Y Acad Sci 851:342–
356.
